IL130094A - תרכובות 2 - אימידזולינילאמינובנזאוקסזול המשמשות כאגוניסטים של אדרנורצפטור אלפא - 2 ותכשירי רוקחות המכילים אותן - Google Patents

תרכובות 2 - אימידזולינילאמינובנזאוקסזול המשמשות כאגוניסטים של אדרנורצפטור אלפא - 2 ותכשירי רוקחות המכילים אותן

Info

Publication number
IL130094A
IL130094A IL13009497A IL13009497A IL130094A IL 130094 A IL130094 A IL 130094A IL 13009497 A IL13009497 A IL 13009497A IL 13009497 A IL13009497 A IL 13009497A IL 130094 A IL130094 A IL 130094A
Authority
IL
Israel
Prior art keywords
dosage range
compounds
usp
alpha
mmol
Prior art date
Application number
IL13009497A
Other languages
English (en)
Other versions
IL130094A0 (en
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL130094A0 publication Critical patent/IL130094A0/xx
Publication of IL130094A publication Critical patent/IL130094A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL13009497A 1996-11-25 1997-11-21 תרכובות 2 - אימידזולינילאמינובנזאוקסזול המשמשות כאגוניסטים של אדרנורצפטור אלפא - 2 ותכשירי רוקחות המכילים אותן IL130094A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3178796P 1996-11-25 1996-11-25
PCT/US1997/020803 WO1998023611A1 (en) 1996-11-25 1997-11-21 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists

Publications (2)

Publication Number Publication Date
IL130094A0 IL130094A0 (en) 2000-02-29
IL130094A true IL130094A (he) 2001-09-13

Family

ID=21861392

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13009497A IL130094A (he) 1996-11-25 1997-11-21 תרכובות 2 - אימידזולינילאמינובנזאוקסזול המשמשות כאגוניסטים של אדרנורצפטור אלפא - 2 ותכשירי רוקחות המכילים אותן

Country Status (18)

Country Link
US (1) US6110952A (he)
EP (1) EP0944622A1 (he)
JP (1) JP2001506601A (he)
KR (1) KR20000069128A (he)
AU (1) AU736992B2 (he)
BR (1) BR9713537A (he)
CA (1) CA2272683A1 (he)
CO (1) CO4910150A1 (he)
CZ (1) CZ183699A3 (he)
HU (1) HUP0002966A3 (he)
ID (1) ID22060A (he)
IL (1) IL130094A (he)
NO (1) NO313755B1 (he)
PE (1) PE16599A1 (he)
SK (1) SK74999A3 (he)
TR (1) TR199901486T2 (he)
WO (1) WO1998023611A1 (he)
ZA (1) ZA9710579B (he)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU736992B2 (en) * 1996-11-25 2001-08-09 Procter & Gamble Company, The 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
WO2000051625A1 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
EP2363129A1 (en) * 2004-10-13 2011-09-07 PTC Therapeutics, Inc. Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseases
CN101355876B (zh) 2005-11-09 2012-09-05 康宾纳特克斯公司 一种适用于眼部给药的组合物
US20110003823A1 (en) * 2008-08-01 2011-01-06 Alpha Synergy Development, Inc. Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage
US20100197694A1 (en) * 2008-08-01 2010-08-05 Gerald Horn Compositions and methods for treatment of diseases and conditions with increased vascular permeability
US20100029662A1 (en) * 2008-08-01 2010-02-04 Alpha Synergy Development, Inc. Vasoconstriction compositions and methods of use
US20100202979A1 (en) * 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of pulmonary diseases and conditions
US8952011B2 (en) 2008-08-01 2015-02-10 Eye Therapies Llc Compositions and methods for the treatment of nasal conditions
US20100203165A1 (en) 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of disorders or conditions of the eye
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
US8987270B2 (en) 2009-07-27 2015-03-24 Eye Therapies Llc Formulations of selective alpha-2 agonists and methods of use thereof
MX336578B (es) * 2011-07-25 2016-01-25 Allergan Inc Derivados de n-(imidazolidin-2-ilideno)-heterociclopenta[b] pirididina como moduladores de receptores de alfa 2 adrenergicos.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795970A (fr) * 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
US3830804A (en) * 1972-11-20 1974-08-20 Eastman Kodak Co Fluorescent(pyrimidinotriazolyl)-2-styrylbenzoxazoles
US4398028A (en) * 1977-01-14 1983-08-09 Sandoz Ltd. Bicyclic heterocyclic amino derivatives
FR2521140A1 (fr) * 1982-02-05 1983-08-12 Synthelabo Derives d'imidazolidine, leur preparation et leur application en therapeutique
US5091528A (en) * 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
GB9110017D0 (en) * 1991-05-09 1991-07-03 Nat Res Dev Spectroscopic investigation using organometallic compounds
ES2160700T3 (es) * 1994-01-24 2001-11-16 Allergan Sales Inc Derivados aromaticos de 2-amino-imidazol como agonistas del adrenorreceptor alfa-2a.
EP0775134A4 (en) * 1994-08-04 1997-08-13 Synaptic Pharma Corp NEW BENZIMIDAZOLE DERIVATIVES
KR100215541B1 (ko) * 1996-04-19 1999-08-16 박원훈 벤족사졸계 비선형 광학 유도체 및 이들로부터 얻어진고분자
AU736992B2 (en) * 1996-11-25 2001-08-09 Procter & Gamble Company, The 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists

Also Published As

Publication number Publication date
HUP0002966A2 (hu) 2001-09-28
PE16599A1 (es) 1999-03-12
KR20000069128A (ko) 2000-11-25
SK74999A3 (en) 2000-02-14
CZ183699A3 (cs) 1999-09-15
NO992500D0 (no) 1999-05-25
AU5438298A (en) 1998-06-22
NO313755B1 (no) 2002-11-25
ZA9710579B (en) 1998-06-25
CA2272683A1 (en) 1998-06-04
US6110952A (en) 2000-08-29
ID22060A (id) 1999-08-26
IL130094A0 (en) 2000-02-29
JP2001506601A (ja) 2001-05-22
BR9713537A (pt) 2000-03-21
HUP0002966A3 (en) 2001-10-29
TR199901486T2 (xx) 1999-10-21
NO992500L (no) 1999-07-26
AU736992B2 (en) 2001-08-09
EP0944622A1 (en) 1999-09-29
WO1998023611A1 (en) 1998-06-04
CO4910150A1 (es) 2000-04-24

Similar Documents

Publication Publication Date Title
EP0944621B1 (en) 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
US6117871A (en) 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists
US6225331B1 (en) Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
US5965595A (en) 2-Imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists
US5916900A (en) 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
US5804587A (en) 6-(2-imidazolinylamino) quinolines useful as alpha-2 adrenoceptor agonists
US6110952A (en) 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
US5914342A (en) 2-imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists
US6306877B1 (en) Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
US6172095B1 (en) Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
EP0944601B1 (en) Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
WO1998046595A1 (en) 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 adrenoceptor agonists
AU5433998A (en) 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonis ts
WO1998023612A1 (en) 2-imidazolinylaminobenzothiazole compounds useful as alpha-2 adrenoceptor agonists

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees